Sam Atkinson

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

Comba Telecom Achieves A HK$600 Million Profit Swing In FY2025

https://open.spotify.com/episode/5q9jIeZrKpi8aHfr6lVUgK?si=e06d62b5c9cc4b32 The 5 Most Surprising Takeaways from Comba Telecom’s 2025 Transformation In the high-stakes world of...

LionGlobal Singapore Physical Gold ETF IPO – The Future Of Gold?

https://open.spotify.com/episode/6kpKs0ZalIOAyg2mowQ4b0?si=ecb285900e944a09 The "Paper Gold" Illusion: 5 Surprising Realities of the LionGlobal Singapore Physical Gold Fund For...

Why Coal Is Making A Comeback For Geo Energy Resources

https://open.spotify.com/episode/6Mnp5thfFyTRy5RzqkuK0V?si=8cc76ce3ca8e4ac5 Why the "Death of Coal" is Complicated: 5 Surprising Truths from Geo Energy’s Radical...

How Prudential Is Rewriting The Insurance Playbook In Asia & Africa – FY2025

https://open.spotify.com/episode/179npbE3EyADJeHJGsLRUy?si=1d98b4cb974c4760 The Inflection Point How does a financial institution with a nearly 180-year heritage maintain double-digit...

What Top Glove’s Q2 FY2026 Comeback Reveals About Their Future

https://open.spotify.com/episode/39mX7dQugKGGzv4pVT0qdZ?si=20a8d898ed414522 The 92% Profit Surge The global manufacturing landscape has been defined by extreme volatility, yet...

Manulife US REIT FY2025 Survival Plan

https://open.spotify.com/episode/0Q7vFX5d2rhOFfaBUXy8dN?si=26dcc38470b84a9d How Manulife US REIT is Rebuilding for a Diversified Future Navigating the US Office Landscape The...

How Renaissance United Is Trading Chinese Gas Woes For An AI-Fueled Tech Surge – Q3 2026

https://open.spotify.com/episode/3Untxmx3sSUqyGcUeOIJfC?si=a9f15312cb004ca7 Introduction In the volatile theater of global markets, the most significant shifts often occur at...

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...

Is Singapore’s Defence Surge A Temporary Spike Or A Permanent Structural Shift?

https://open.spotify.com/episode/6h424sB5CIQZwa6PQEKEWv?si=076ee9e376f44d71 Why the Death of the "Peace Dividend" is a Multi-Decade Tailwind for Defense Industrials In...

UI Boustead REIT’s IPO – Are They Redefining The Industrial Playbook?

https://open.spotify.com/episode/1FRSiKbovzXyNjGCT9b931?si=6b335927b60f498d 5 Reasons UI Boustead REIT is Redefining the Industrial Playbook For the uninitiated, industrial real...

China Aviation Oil Dominates Jet Fuel Supply

https://open.spotify.com/episode/7DJ9PIClq14eEsV4ioIJ3Q?si=6cf2e704c16b42f0 5 Takeaways from China Aviation Oil’s Record Year While mainstream investors scramble to play the...

Tech Gains Drive EnGro Concrete’s FY2025 Profit Surge

https://open.spotify.com/episode/5uzGUx8kHXYBQxhFdmDy8Y?si=3d9d4894dd9d4d7e More Than Just Concrete: 5 Surprising Insights from EnGro’s Massive FY2025 Turnaround In the landscape...

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...